Holen Sie sich die Stockscreener-App
3.08
0.00%
0.00
Handel nachbörslich:
3.08
Schlusskurs vom Vortag:
$3.08
Offen:
$3.07
24-Stunden-Volumen:
601.43K
Relative Volume:
1.11
Marktkapitalisierung:
$212.91M
Einnahmen:
$115.02M
Nettoeinkommen (Verlust:
$-68.73M
KGV:
-3.2917
EPS:
-0.9357
Netto-Cashflow:
$-53.22M
1W Leistung:
+5.48%
1M Leistung:
-3.45%
6M Leistung:
-3.75%
1J Leistung:
-0.96%
1-Tages-Spanne:
$3.055
$3.13
1-Wochen-Bereich:
$2.8254
$3.13
52-Wochen-Spanne:
$2.08
$3.82
Orasure Technologies Inc Stock (OSUR) Company Profile
Firmenname
Orasure Technologies Inc
Sektor
Telefon
(503) 641-6115
Adresse
220 E FIRST ST, BETHLEHEM, PA
Compare OSUR vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OSUR
Orasure Technologies Inc
|
3.08 | 212.91M | 115.02M | -68.73M | -53.22M | -0.9357 |
ISRG
Intuitive Surgical Inc
|
452.58 | 160.56B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
155.32 | 43.95B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
74.63 | 36.34B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
43.88 | 35.94B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
224.93 | 32.65B | 5.40B | 1.49B | 1.78B | 10.12 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-03 | Fortgesetzt | Evercore ISI | In-line |
| 2021-09-22 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-08-21 | Eingeleitet | Evercore ISI | Outperform |
| 2020-08-10 | Eingeleitet | Citigroup | Buy |
| 2020-08-10 | Eingeleitet | JP Morgan | Neutral |
| 2020-08-07 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-06-25 | Eingeleitet | Lake Street | Buy |
| 2020-04-21 | Fortgesetzt | Stephens | Equal-Weight |
| 2018-10-23 | Fortgesetzt | Raymond James | Mkt Perform |
| 2018-07-16 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2017-11-02 | Herabstufung | Jefferies | Buy → Hold |
| 2017-02-09 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2016-06-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-11-05 | Bestätigt | Mizuho | Buy |
| 2015-05-07 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2015-01-23 | Bestätigt | Mizuho | Buy |
| 2014-06-12 | Bestätigt | Canaccord Genuity | Buy |
| 2014-06-11 | Bestätigt | Mizuho | Buy |
| 2012-12-21 | Eingeleitet | Mizuho | Buy |
| 2012-08-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2012-07-05 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2012-03-27 | Eingeleitet | JMP Securities | Mkt Outperform |
Alle ansehen
Orasure Technologies Inc Aktie (OSUR) Neueste Nachrichten
Drug Screening Market Trends 2026–2031: Chromatography and Mass Spectrometry Held a 44.77% Share in 2025 Amid Growing Demand for Advanced Testing, Reports Mordor Intelligence - GlobeNewswire Inc.
Why OraSure Technologies, Inc. Shares Jumped - Yahoo
Growth Value: Why is OraSure Technologies Inc stock going up2026 Trading Volume Trends & Stepwise Trade Execution Plans - baoquankhu1.vn
OraSure Defends Strategy Amid Activist Altai Governance Challenge - The Globe and Mail
Activist Altai Capital pushes for OraSure sale, board seats (update) - MSN
OraSure Technologies Stock Crosses Above 200-Day Moving Average - National Today
OraSure Technologies (NASDAQ:OSUR) Stock Crosses Above 200-Day Moving AverageHere's What Happened - marketbeat.com
Ideas Watch: Is OraSure Technologies Inc being accumulated by smart money2026 Selloffs & Smart Allocation Stock Reports - baoquankhu1.vn
OraSure Technologies Inc (OSUR) Stock Price Quote Today & Current Price Chart - Capital.com
OraSure (OSUR) director receives stock grant with tax withholding on vested shares - stocktitan.net
OraSure rebuts Altai, cites near-term FDA milestones, cash balance and path to cash-flow breakeven - TradingView
OraSure Technologies Issues a Presentation to its Shareholders - marketscreener.com
[8-K] ORASURE TECHNOLOGIES INC Reports Material Event - stocktitan.net
OSUR PE Ratio & Valuation, Is OSUR Overvalued - Intellectia AI
OraSure Technologies (OSUR) price target decreased by 11.11% to 4.08 - MSN
Trade Report: What is ONBPPs valuation compared to sector2026 News Drivers & Precise Swing Trade Alerts - baoquankhu1.vn
Vanguard disaggregates holdings; OraSure (OSUR) shows 0 shares reported - stocktitan.net
OraSure CEO Buys 32,300 Shares, Increasing Stake by 1.5% - National Today
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Insider Buying: Kenneth Mcgrath Acquires Shares of OraSure Techn - GuruFocus
Manner Carrie Eglinton Acquires 32,300 Shares of OraSure Technologies (NASDAQ:OSUR) Stock - marketbeat.com
Insider Buying: OraSure Technologies (NASDAQ:OSUR) CFO Purchases 32,300 Shares of Stock - MarketBeat
OraSure CFO McGrath buys $94,600 in company stock By Investing.com - Investing.com Canada
OraSure (OSUR) president & CEO Eglinton buys $94,597 in shares By Investing.com - Investing.com India
OraSure (OSUR) president & CEO Eglinton buys $94,597 in shares - Investing.com UK
OraSure Technologies (OSUR) CFO adds 32,300 shares in planned buy - Stock Titan
OraSure (OSUR) CEO adds 32,300 shares in pre-planned 10b5-1 buy - Stock Titan
Altai Capital Management Reduces Stake in OraSure Technologies - GuruFocus
[Form 4] ORASURE TECHNOLOGIES INC Insider Trading Activity - Stock Titan
Activists Turn Up The Heat On Deals And Buybacks - Finimize
Sentiment Review: Is OraSure Technologies Inc attractive for institutional investors2026 Action & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Exclusive: Altai Capital presses OraSure to sell and give it board seats, letter says - Reuters
Altai Capital presses OraSure board for overhaul, nominates two directors - MSN
Altai Calls for Strategic Review at Orasure - marketscreener.com
Investor pressures OraSure for board seats, exploration of possible sale - WFMZ.com
Altai Capital Presses OraSure Board For Overhaul, Nominates Two Directors - Benzinga
Altai Capital pushes for board seats at OraSure Technologies By Investing.com - Investing.com South Africa
Altai Capital (OSUR) builds 5.2% OraSure stake and plans proxy fight - Stock Titan
Activist Altai Capital pushes for OraSure sale, board seats (update) (OSUR:NASDAQ) - Seeking Alpha
Orasure highlights significant operational progress following letter from Altai Capital - marketscreener.com
Altai Capital (OSUR) Seeks Board Seats, Urges Strategic Review and Sale - Stock Titan
OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital - The Manila Times
OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter From Altai Capital - 富途牛牛
Altai Capital Pushes for OraSure (OSUR) Sale to Double Share Val - GuruFocus
Altai Capital Management Issues Letter to OraSure Board - marketscreener.com
Altai Capital pushes for board seats at OraSure Technologies - Investing.com
Altai Capital pushes for OraSure board seats amid performance concerns By Investing.com - Investing.com Australia
Altai Capital Urges OraSure Technologies Board to Address Operational Inefficiencies and Leadership Concerns - geneonline.com
Altai Capital pushes for OraSure board seats amid performance concerns - StreetInsider
Altai Capital Management Issues Letter to OraSure Board Outlining Five-Pillar Case for Change in Response to Significant and Continued Underperformance - chartmill.com
Altai Capital presses OraSure to sell and give it board seats, letter says - marketscreener.com
Finanzdaten der Orasure Technologies Inc-Aktie (OSUR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Orasure Technologies Inc-Aktie (OSUR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| EGLINTON MANNER CARRIE | President & CEO |
Mar 20 '26 |
Buy |
2.93 |
32,300 |
94,597 |
2,190,874 |
| McGrath Kenneth J | Chief Financial Officer |
Mar 13 '26 |
Buy |
3.00 |
22,021 |
66,030 |
557,262 |
| EGLINTON MANNER CARRIE | President & CEO |
Mar 13 '26 |
Buy |
3.00 |
22,022 |
66,033 |
2,158,574 |
0.50%
0.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):